Last reviewed · How we verify

intracoronary infusion of acetylcholine

Azienda Ospedaliera San Camillo Forlanini · Phase 1 active Small molecule

intracoronary infusion of acetylcholine is a Small molecule drug developed by Azienda Ospedaliera San Camillo Forlanini. It is currently in Phase 1 development. Also known as: cypher coroflex.

At a glance

Generic nameintracoronary infusion of acetylcholine
Also known ascypher coroflex
SponsorAzienda Ospedaliera San Camillo Forlanini
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about intracoronary infusion of acetylcholine

What is intracoronary infusion of acetylcholine?

intracoronary infusion of acetylcholine is a Small molecule drug developed by Azienda Ospedaliera San Camillo Forlanini.

Who makes intracoronary infusion of acetylcholine?

intracoronary infusion of acetylcholine is developed by Azienda Ospedaliera San Camillo Forlanini (see full Azienda Ospedaliera San Camillo Forlanini pipeline at /company/azienda-ospedaliera-san-camillo-forlanini).

Is intracoronary infusion of acetylcholine also known as anything else?

intracoronary infusion of acetylcholine is also known as cypher coroflex.

What development phase is intracoronary infusion of acetylcholine in?

intracoronary infusion of acetylcholine is in Phase 1.

Related